Shahid Gilani, MD from the University Hospital Of North Midlands speaks about the Direct Oral Anticoagulants (DOACs) in Cancer-Related Thromboembolism.
Link to Article:
https://www.actascientific.com/ASCB/pdf/ASCB-04-0257.pdf
Shahid Gilani, MD @sngilani @UHNM_NHS #VariousCancers #cancer #research Direct Oral Anticoagulants (DOACs) in Cancer Related Thromboembolism
By Editor